Back to Archived Journals » International Journal of Interferon, Cytokine and Mediator Research » Volume 2

Pharmacological role and clinical applications of interleukin-6 in rheumatoid disease

Authors Youinou P, Hillion S, Tobón GJ, Cornec D, Pers J, Saraux A, Bendaoud B, Renaudineau Y, Jamin C

Published 20 April 2010 Volume 2010:2 Pages 33—39

DOI https://doi.org/10.2147/IJICMR.S7041

Review by Single-blind

Peer reviewer comments 3


Pierre Youinou1,2, Sophie Hillion1,2, Gabriel J Tobón1,2, Divi Cornec1,2, Jacques-Olivier Pers1,2, Alain Saraux1,2, Boutahar Bendaoud1,2, Yves Renaudineau1,2, Christophe Jamin1,2

1Université Européenne de Bretagne and Université de Brest, “Immunology and Pathology”, 2ScInBioS, Brest, France; University Medical School Hospital, Brest, France

Abstract: Interleukin (IL)-6 is a pleiotropic cytokine that promotes polyclonal activation of B lymphocytes. This implies that its deregulation favors inflammatory conditions. Through the association of the transducing glycoprotein 130 with the membrane-anchored receptor (R) α, IL-6 can generate functionally distinct signals. Given these particular molecular aspects, numerous activities ascribed to this cytokine are, in fact, due to the insertion into soluble IL-6Rα. The system is instrumental in rheumatoid arthritis (RA), Sjögren’s syndrome and systemic lupus erythematosus (SLE). In this respect, it is interesting that the expression of the recombination-activating gene is sustained by IL-6 in B lymphocytes, and repressed by anti-IL-6R antibody (Ab) in RA and SLE. Agents that inhibit IL-6 signaling have now entered clinical trials. As expected, clinical benefits are reported in the treatment of autoimmune disorders with anti-IL-6R Ab, but other perspectives remain open in the forthcoming biotherapies of immune-mediated disorders.

Keywords: interleukin-6, B lymphocyte, rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome, biotherapy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]